Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients

Clinical Endocrinology

Volumn 61, Issue 4, 2004, Pages 515-521

  Yavuz, Dilek Gogas ^a,b   Yüksel, Meral ^b   Deyneli, Oguzhan ^a   Ozen, Yesim ^a   Aydin, Hasan ^a   Akalin, Sema ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; LEVOTHYROXINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN; PROPYLTHIOURACIL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EUTHYROIDISM; FEMALE; HUMAN; HYPERTHYROIDISM; IATROGENIC DISEASE; INSULIN SENSITIVITY; LIOTHYRONINE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NODULAR GOITER; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SPECTROPHOTOMETRY; THYROXINE BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; ANTITHYROID AGENTS; ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; FEMALE; GOITER, NODULAR; HUMANS; HYPERTHYROIDISM; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROPYLTHIOURACIL; THYROID FUNCTION TESTS;

EID: 6344292618     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02123.x     Document Type: Article

References (28)

1. Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaiger, C.L., Newton, R.S. & La Du, B.N. (1999) Human serum paraoxonase (PONl) is inactivated by oxidized low-density lipoprotein and preserved by antioxidants. Free Radical Biology and Medicine, 26, 892-904.
2. Azizi, F., Raiszadeh, F., Solati, M., Etemadi, A., Rahmani, M. & Arabi, M. (2003) Serum paraoxonase 1 activity is decreased in thyroid dysfunction. Journal of Endocrinological Investigations, 26, 703-709.
3. Benvenga, S., Allesci, S. & Trimarchi, F. (2002) High-density lipoprotein-facilitated entry of thyroid hormones into cells: a mechanism different from the low-density lipoprotein-facilitated entry. Thyroid, 12, 547-556.
4. Biachi, G., Solaroli, E., Zaccheroni, V., Grossi, G., Bargossi, A.M., Melchionda, N. & Marchesini, G. (1999) Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Hormone and Metabolism Research, 3, 620-624.
5. Blondi, B., Palmieri, E.A., Lombardi, G. & Fazio, S. (2002) Effects of subclinical thyroid dysfunction on the heart. Annals of Internal Medicine, 137, 907-914.
6. Constantini, F., Pierdomenico, S.D., De Cesare, D., De Remigis, Bucciarelli, T., Bittolo-Bon, G., Cazzolato, G., Nubile, G., Guagnano, M.T., Sensi, S., Cuccurullo, F. & Andrea Mezzetti, A. (1998) Effect of thyroid function on LDL oxidation. Arteriolosclerosis, Thrombosis and Vascular Biology, 18, 732-737.
7. Duntas, L.H. (2002) Thyroid disease and lipids. Thyroid, 12, 287-293.
8. Fernanadez, V., Barrientos, X., Kipreos, K., Valenzuela, A. & Videla, L.A. (1985) Superoxide radical generation, NADPH oxidase activity and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology, 111, 496-501.
9. Gonzalo, M.A., Grant, C., Moreno, I., Garcia, F.J., Suarez, A.I., Herrera-Pombo, J.L. & Rovira, A. (1996) Glucose tolerance, insulin secretion, insulin sensitivity and glucose effectiveness in normal and overweight hyperthyroid women. Clinical Endocrinology, 45, 689-697.
10. Jap, T.S., Ho, L.T. & Won, J.G. (1989) Insulin secretion and sensitivity in hyperthyroidism. Hormone and Metabolism Research, 21, 261-266.
11. Kinlaw, W.B. (1995) Thyroid disorders and cholesterol: identifying the realm of clinical relevance. Endocrinologist, 5, 148-155.
12. Kordonouri, O., James, R. W., Bennets, B., Chan, Y.L., Kao, T., Danne, M., Silink, M. & Donaghue, K. (2001) Modulation of blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus. Metabolism, 50, 657-660.
13. Mackness, M.I., Arrol, S. & Durrington, P.N. (1991a) Paraoxonse prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letters, 286, 152-154.
14. Mackness, M.I., Harty, D., Bhatnagar, D., Winocour, P.H., Arrol, S. & Ishaola Mi Durrington, P.N. (1991b) Serum paraoxonse activity in familial hypercholestorelemia and insulin dependent diabetes mellitus. Atherosclerosis, 86, 193-199.
15. Mackness, M.I., Arrol, S., Abbott, C.A. & Durrington, P.N. (1993b) Protection low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis, 104, 129-135.
16. Mackness, M.I., Arrol, S. & Durrington, P.N. (1993a) Paraoxonse prevents accumulation of lipoperoxides in low density lipoprotein. FEBS Letters, 286, 152-154.
17. Mackness, M.I., Mackness, B., Durrington, P.N., Connelly, P.W. & Hegele, R.A. (1996) Paraoxonase: biochemistry, genetics and relationship to plasma proteins. Current Opinions in Lipidology, 7, 69-76.
18. Mackness, M.I., Mackness, B. & Durrinton, P.N. (2002) Paraoxonse and coronary heart disease. Atherosclerosis supplement, 3, 49-55.
19. Matsuda, M. & DeFronzo, R.A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care, 22, 1462-1470.
20. O'Meara, N.M., Blackman, J.D., Sturis, J. & Polonsky, K.S. (1993) Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 76, 79-84.
21. Raiszadeh, F., Solati, M.A., Etemadi, A. & Azizi, F. (2004) Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clinical Endocrinology, 60, 75-80.
22. Senti, M., Tomas, M., Villa, J., Marrugat, J., Elosua, R., Sala, J. & Masia, R. (2001) Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase gene: the Regicor Study. Atherosclerosis, 156, 443-449.
23. Shih, D.M., Gu, L., Xia, Y.R., Navab, M., Li, W.F., Hama, S., Castellani, L.W., Furlog, C.E., Costa, L.G. & Fogelman, A.M. (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature, 394, 284-287.
24. Steinbrecher, U.P., Parthasarathy, S., Leake, D., Witztum, J.R. & Steinberg, D. (1984) Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proceedings of the National Academy of Sciences of the USA, 81, 3883-3887.
25. Sundaram, V., Hanna, A., Koneru, L., Newman, A.I. & Falko, J. (1997) Both hypothyroidism and hyperthyroidism enhance low-density lipoprotein oxidation. Journal of Clinical Endocrinology and Metabolism, 82, 3421-3424.
26. Van Lenten, B.J., Wagner, A.C., Nayak, O.P., Kama, S., Navab, M. & Fogelman, A.M. (2001) High-density lipoprotein losses its anti-inflammatory properties during acute influenza infection. Circulation, 103, 2283-2288.
27. Videla, L.A., Sir, T. & Wolff, C. (1988) Increased lipid per oxidation in hyperthyroid patients: suppression by propylthiouracil treatment. Free Radical Research Communications, 5, 1-10.
28. Yamada, A., Shojo, X., Tahara, T., Emoto, M. & Nishizawa, Y. (2001) Effect of insulin resistance on serum paraoxonase activity in a non-diabetic population. Metabolism, 50, 805-811.